Wells Fargo
ETRM

Wells Fargo’s EnteroMedics Inc. ETRM Stock Holding History

Wells Fargo’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-158
Closed -$3K – 6688
2016
Q2 		$3K Sell
158
-1,017
-87% -$46.6K ﹤0.01% 5932
2016
Q1 		$80K Buy
1,175
+43
+4% +$3.47K ﹤0.01% 5001
2015
Q4 		$155K Sell
1,132
-275
-20% -$57K ﹤0.01% 4621
2015
Q3 		$384K Buy
1,407
+88
+7% +$28.1K ﹤0.01% 4111
2015
Q2 		$858K Sell
1,319
-19
-1% -$21.9K ﹤0.01% 3719
2015
Q1 		$1.28M Sell
1,338
-128
-9% -$154K ﹤0.01% 3349
2014
Q4 		$2.19M Sell
1,466
-119
-8% -$161K ﹤0.01% 2949
2014
Q3 		$2.05M Sell
1,585
-104
-6% -$152K ﹤0.01% 2984
2014
Q2 		$2.77M Sell
1,689
-1,035
-38% -$1.94M ﹤0.01% 2788
2014
Q1 		$5.21M Sell
2,724
-377
-12% -$893K ﹤0.01% 2290
2013
Q4 		$6.64M Sell
3,101
-388
-11% -$625K ﹤0.01% 2042
2013
Q3 		$4.56M Sell
3,489
-334
-9% -$389K ﹤0.01% 2262
2013
Q2 		$4.58M Buy
+3,823
New +$4.04M ﹤0.01% 2195

Other funds holding ETRM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Wells Fargo's ETRM Position: Q3 2016 in Review

Wells Fargo sold out of EnteroMedics Inc. (ETRM) in Q3 2016, closing a stake of 158 shares — an estimated $3K sold.

Wells Fargo first reported a position in ETRM in Q2 2013 and held it in 13 quarters. The position peaked at $6.64M in Q4 2013. 20 funds tracked by Wall St. Rank hold ETRM as of Q3 2016.

  • Wells Fargo reported no remaining EnteroMedics Inc. position as of Q3 2016 after selling out during the quarter.
  • Wells Fargo sold 158 EnteroMedics Inc. shares in Q3 2016, an estimated $3K.
  • Wells Fargo first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 13 quarters.
  • Wells Fargo's EnteroMedics Inc. position peaked at $6.64M in Q4 2013.
  • 20 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2016.

Based on Wells Fargo's 13F filing for Q3 2016, filed 31 Oct 2016.